Cargando…

Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review

Cardiopulmonary bypass is an integral and indispensable part of surgical repair of congenital heart defects. While the complications and morbidity secondary to the use of cardiopulmonary bypass has decreased considerably, there remains a significant incidence of clinically relevant renal and neurolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramakrishnan, Karthik, Kumar, Tk Susheel, Boston, Umar S., Allen, Jerry, Knott-Craig, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416123/
https://www.ncbi.nlm.nih.gov/pubmed/37575895
http://dx.doi.org/10.21037/tp-23-94
_version_ 1785087702028255232
author Ramakrishnan, Karthik
Kumar, Tk Susheel
Boston, Umar S.
Allen, Jerry
Knott-Craig, Christopher J.
author_facet Ramakrishnan, Karthik
Kumar, Tk Susheel
Boston, Umar S.
Allen, Jerry
Knott-Craig, Christopher J.
author_sort Ramakrishnan, Karthik
collection PubMed
description Cardiopulmonary bypass is an integral and indispensable part of surgical repair of congenital heart defects. While the complications and morbidity secondary to the use of cardiopulmonary bypass has decreased considerably, there remains a significant incidence of clinically relevant renal and neurological injury. To provide more physiological delivery of oxygenated blood to the end-organs, our center has been successfully using a high-flow, high hematocrit cardiopulmonary bypass strategy since 2006. The essential components of this strategy include maintaining high flows (typically 200 mL/kg/min in neonates, 150–175 mL/kg/min in older infants weighing <10 kg, and 2.6 L/min/m(2) in older children) throughout the duration of cardiopulmonary bypass irrespective of patient temperature, as well as maintaining a hematocrit of at least 32% on cardiopulmonary bypass. The incidence of post-operative acute kidney injury (around 3%) and clinical acute neurological events (<1%) with this strategy is considerably less when compared to other contemporary publications using the conventional cardiopulmonary bypass strategy. In this review, we discuss the rationale behind our approach and present evidence to support the high-flow, high-hematocrit strategy. We also discuss the practical aspects of our strategy and describe the adjuncts we use to derive additional benefits. These adjuncts include the use of a hybrid pH/alpha stat strategy during cooling/rewarming, aggressive use of conventional ultrafiltration during cardiopulmonary bypass, a terminal hematocrit of 40–45%, and avoidance of milrinone and albumin in the early peri-operative period. This results in a very low incidence of post-operative bleeding, facilitates chest closure in the operating room even in most neonates, helps in reducing the need for post-operative blood product transfusion and helps in achieving a favorable post-operative fluid balance early after surgery.
format Online
Article
Text
id pubmed-10416123
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-104161232023-08-12 Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review Ramakrishnan, Karthik Kumar, Tk Susheel Boston, Umar S. Allen, Jerry Knott-Craig, Christopher J. Transl Pediatr Review Article on Pediatric Heart Cardiopulmonary bypass is an integral and indispensable part of surgical repair of congenital heart defects. While the complications and morbidity secondary to the use of cardiopulmonary bypass has decreased considerably, there remains a significant incidence of clinically relevant renal and neurological injury. To provide more physiological delivery of oxygenated blood to the end-organs, our center has been successfully using a high-flow, high hematocrit cardiopulmonary bypass strategy since 2006. The essential components of this strategy include maintaining high flows (typically 200 mL/kg/min in neonates, 150–175 mL/kg/min in older infants weighing <10 kg, and 2.6 L/min/m(2) in older children) throughout the duration of cardiopulmonary bypass irrespective of patient temperature, as well as maintaining a hematocrit of at least 32% on cardiopulmonary bypass. The incidence of post-operative acute kidney injury (around 3%) and clinical acute neurological events (<1%) with this strategy is considerably less when compared to other contemporary publications using the conventional cardiopulmonary bypass strategy. In this review, we discuss the rationale behind our approach and present evidence to support the high-flow, high-hematocrit strategy. We also discuss the practical aspects of our strategy and describe the adjuncts we use to derive additional benefits. These adjuncts include the use of a hybrid pH/alpha stat strategy during cooling/rewarming, aggressive use of conventional ultrafiltration during cardiopulmonary bypass, a terminal hematocrit of 40–45%, and avoidance of milrinone and albumin in the early peri-operative period. This results in a very low incidence of post-operative bleeding, facilitates chest closure in the operating room even in most neonates, helps in reducing the need for post-operative blood product transfusion and helps in achieving a favorable post-operative fluid balance early after surgery. AME Publishing Company 2023-07-17 2023-07-31 /pmc/articles/PMC10416123/ /pubmed/37575895 http://dx.doi.org/10.21037/tp-23-94 Text en 2023 Translational Pediatrics. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Review Article on Pediatric Heart
Ramakrishnan, Karthik
Kumar, Tk Susheel
Boston, Umar S.
Allen, Jerry
Knott-Craig, Christopher J.
Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review
title Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review
title_full Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review
title_fullStr Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review
title_full_unstemmed Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review
title_short Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review
title_sort cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review
topic Review Article on Pediatric Heart
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416123/
https://www.ncbi.nlm.nih.gov/pubmed/37575895
http://dx.doi.org/10.21037/tp-23-94
work_keys_str_mv AT ramakrishnankarthik cardiopulmonarybypassinneonatesandinfantsadvantagesofhighflowhighhematocritbypassstrategyclinicalpracticereview
AT kumartksusheel cardiopulmonarybypassinneonatesandinfantsadvantagesofhighflowhighhematocritbypassstrategyclinicalpracticereview
AT bostonumars cardiopulmonarybypassinneonatesandinfantsadvantagesofhighflowhighhematocritbypassstrategyclinicalpracticereview
AT allenjerry cardiopulmonarybypassinneonatesandinfantsadvantagesofhighflowhighhematocritbypassstrategyclinicalpracticereview
AT knottcraigchristopherj cardiopulmonarybypassinneonatesandinfantsadvantagesofhighflowhighhematocritbypassstrategyclinicalpracticereview